Pharmagal Bio Pharmavac PHA

Description:
Pharmavac PHA

Pharmavac PHA is a emulsion for injection for pigeons.

Content:
One vaccine dose (0.3 ml) contains:

Active substances:
Inactivated Pigeon Paramyxovirus type 1 (PPMV1), strain 988M  ≥ 6,9 log2 HI*
Inactivated Pigeon Herpesvirus 1 (PHV1), V298/70 ≥ 38,1 EU**
Inactivated Fowl Adenovirus type 8 (FAdV-8), strain M2/E ≥ 24,7 EU**
* Haemagglutination inhibition units in chicken.
** ELISA units in chicken.

Indication:
Pharmavac PHA is for active immunization of pigeons from the age of 4 weeks onwards:
–      to reduce mortality and frequency and severity of clinical signs caused by paramyxovirus type 1 (PMV1).
–      to reduce the severity of clinical signs, gross lesions and virus shedding caused by pigeon herpesvirus (PHV1).
–      to reduce the severity of clinical signs and gross lesions caused by adenovirus (AdV) namely type 7/E, 2/D, 3/D and 4/C belonging to subgroup I
Onset of immunity: 3 weeks after vaccination.
Duration of immunity:
12 months after vaccination for PMV1 component.
5 months after vaccination for PHV1 and AdV component.
The duration of immunity against PHV1 and AdV was demonstrated by cell-mediated immunity and serological data.

Dosage and route of administration:
One dose: 0.3 ml
Administer one dose subcutaneously in the dorsal region of the neck towards the tail (not to the head) from 4 weeks of age onwards.
Shake well before and occasionally during administration.
Before administration allow warming of vaccine to room temperature.
Administer under usual aseptic conditions using sterile syringes and needles only.
Use appropriately graduated syringes allowing administration of the exact vaccination dose 0.3 ml.

Recommended vaccination scheme:
Primovaccinaction: 1 dose from 4 weeks of age onwards.
Revaccination: every 12 months for PMV1 component and in breeding with presence of PHV1 and AdV every 5 months.

Storage conditions:
Store in a refrigerator (2 °C – 8 °C).
Protect from frost. Protect from light.